CoreFirst Bank & Trust’s Pfizer PFE Stock Holding History

CoreFirst Bank & Trust’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$91.8K	Hold	3,811	–	–	0.05%	168
2026 Q1	$107K	Sell	3,811 -686	-15%	-$18.3K	0.06%	154
2025 Q4	$112K	Sell	4,497 -1,500	-25%	-$37.8K	0.06%	149
2025 Q3	$153K	Hold	5,997	–	–	0.08%	130
2025 Q2	$145K	Buy	+5,997	New	+$140K	0.08%	132
2025 Q1	–	Sell	-8,534	Closed	-$226K	–	284
2024 Q4	$226K	Sell	8,534 -900	-10%	-$24.4K	0.13%	110
2024 Q3	$273K	Sell	9,434 -327	-3%	-$9.54K	0.16%	106
2024 Q2	$273K	Sell	9,761 -19,122	-66%	-$526K	0.18%	104
2024 Q1	$802K	Sell	28,883 -13,273	-31%	-$368K	0.5%	46
2023 Q4	$1.21M	Sell	42,156 -1,011	-2%	-$30.6K	0.81%	33
2023 Q3	$1.43M	Buy	43,167 +1,966	+5%	+$69.5K	1.02%	24
2023 Q2	$1.51M	Sell	41,201 -2,326	-5%	-$90.5K	1.06%	24
2023 Q1	$1.78M	Sell	43,527 -1,380	-3%	-$59.6K	1.29%	17
2022 Q4	$2.3M	Buy	44,907 +108	+0.2%	+$5.18K	1.75%	9
2022 Q3	$1.96M	Sell	44,799 -550	-1%	-$26.7K	1.69%	11
2022 Q2	$2.38M	Buy	45,349 +265	+0.6%	+$13.5K	1.88%	10
2022 Q1	$2.33M	Sell	45,084 -349	-0.8%	-$18.1K	1.6%	12
2021 Q4	$2.68M	Hold	45,433	–	–	1.74%	10
2021 Q3	$1.96M	Buy	45,433 +683	+2%	+$30.3K	1.36%	13
2021 Q2	$1.75M	Sell	44,750 -683	-2%	-$26.6K	1.19%	17
2021 Q1	$1.65M	Hold	45,433	–	–	1.13%	18
2020 Q4	$1.67M	Buy	+45,433	New	+$1.67M	1.24%	16

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CoreFirst Bank & Trust's PFE Position: Q2 2026 in Review

CoreFirst Bank & Trust held its Pfizer (PFE) position steady in Q2 2026 at 3,811 shares worth $91.8K. The position accounts for 0.05% of the portfolio, ranked #168.

CoreFirst Bank & Trust first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $2.68M in Q4 2021. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

CoreFirst Bank & Trust held 3,811 shares of Pfizer worth $91.8K as of Q2 2026.
CoreFirst Bank & Trust left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.05% of CoreFirst Bank & Trust's portfolio in Q2 2026, its #168 holding.
CoreFirst Bank & Trust first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
CoreFirst Bank & Trust's Pfizer position peaked at $2.68M in Q4 2021.
2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on CoreFirst Bank & Trust's 13F filing for Q2 2026, filed 5 Aug 2026.